The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke

BACKGROUND: Intravenous recombinant tissue plasminogen activator (rt-PA) is approved for use in selected patients with ischaemic stroke within 3 hours of symptom onset. IST-3 seeks to determine whether a wider range of patients may benefit. DESIGN: International, multi-centre, prospective, randomize...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Sandercock, Peter, Lindley, Richard, Wardlaw, Joanna, Dennis, Martin, Lewis, Steff, Venables, Graham, Kobayashi, Adam, Czlonkowska, Anna, Berge, Eivind, Slot, Karsten Bruins, Murray, Veronica, Peeters, Andre, Hankey, Graeme, Matz, Karl, Brainin, Michael, Ricci, Stefano, Celani, Maria Grazia, Righetti, Enrico, Cantisani, Teresa, Gubitz, Gord, Phillips, Steve, Arauz, Antonio, Prasad, Kameshwar, Correia, Manuel, Lyrer, Phillippe
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2008
Teme:
Study Protocol
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2442584/
https://ncbi.nlm.nih.gov/pubmed/18559104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-9-37
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items